Search by Drug Name or NDC

    NDC 00023-5773-30 REFRESH Optive Mega-3 5; 10; 5 mg/mL; mg/mL; mg/mL Details

    REFRESH Optive Mega-3 5; 10; 5 mg/mL; mg/mL; mg/mL

    REFRESH Optive Mega-3 is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80.

    Product Information

    NDC 00023-5773
    Product ID 0023-5773_0880d5b4-a8c6-4bf1-be8f-933e68fa5130
    Associated GPIs 86209903202022
    GCN Sequence Number 070905
    GCN Sequence Number Description carboxymethyl/gly/poly80/PF DROPERETTE 0.5-1-0.5% OPHTHALMIC
    HIC3 Q6T
    HIC3 Description ARTIFICIAL TEARS
    GCN 34571
    HICL Sequence Number 040248
    HICL Sequence Number Description CARBOXYMETHYLCELLULOSE SODIUM/GLYCERIN/POLYSORBATE 80/PF
    Brand/Generic Brand
    Proprietary Name REFRESH Optive Mega-3
    Proprietary Name Suffix n/a
    Non-Proprietary Name Carboxymethylcellulose sodium, Glycerin and Polysorbate 80
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 5; 10; 5
    Active Ingredient Units mg/mL; mg/mL; mg/mL
    Substance Name CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M018
    Listing Certified Through 2024-12-31

    Package

    NDC 00023-5773-30 (00023577330)

    NDC Package Code 0023-5773-30
    Billing NDC 00023577330
    Package 30 VIAL, SINGLE-USE in 1 BOX (0023-5773-30) / .4 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2017-05-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.44401
    Pricing Unit EA
    Effective Date 2023-11-22
    NDC Description REFRESH OPTIVE MEGA-3 DROPS
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 2, 5, 6
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis